Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Return on Equity (2016 - 2025)

Historic Return on Equity for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to 1.02%.

  • Silo Pharma's Return on Equity fell 4400.0% to 1.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.02%, marking a year-over-year decrease of 4400.0%. This contributed to the annual value of 0.78% for FY2024, which is 7800.0% down from last year.
  • Latest data reveals that Silo Pharma reported Return on Equity of 1.02% as of Q3 2025, which was down 4400.0% from 1.1% recorded in Q2 2025.
  • Silo Pharma's 5-year Return on Equity high stood at 0.0% for Q4 2022, and its period low was 1.1% during Q2 2025.
  • In the last 5 years, Silo Pharma's Return on Equity had a median value of 0.44% in 2023 and averaged 0.43%.
  • The largest annual percentage gain for Silo Pharma's Return on Equity in the last 5 years was 19000bps (2021), contrasted with its biggest fall of -79200bps (2021).
  • Over the past 5 years, Silo Pharma's Return on Equity (Quarter) stood at 0.03% in 2021, then surged by 100bps to 0.0% in 2022, then crashed by -633182bps to 0.66% in 2023, then dropped by -12bps to 0.74% in 2024, then tumbled by -38bps to 1.02% in 2025.
  • Its last three reported values are 1.02% in Q3 2025, 1.1% for Q2 2025, and 1.02% during Q1 2025.